Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
7223 | 1315 | 41.9 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
994 | 9968 | IDIOPATHIC PULMONARY FIBROSIS//USUAL INTERSTITIAL PNEUMONIA//PULMONARY ALVEOLAR PROTEINOSIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | BLEOMYCIN | Author keyword | 37 | 15% | 17% | 226 |
2 | PULMONARY FIBROSIS | Author keyword | 26 | 13% | 15% | 195 |
3 | LUNG FIBROSIS | Author keyword | 10 | 15% | 5% | 65 |
4 | LUNG CELLULAR MOL BIOL | Address | 6 | 40% | 1% | 12 |
5 | MED SL9 | Address | 4 | 75% | 0% | 3 |
6 | MALLORY PATHOL | Address | 4 | 28% | 1% | 12 |
7 | BLEOMYCIN INDUCED LUNG INJURY | Author keyword | 3 | 57% | 0% | 4 |
8 | LUNG BIOL PROGRAM | Address | 3 | 20% | 1% | 15 |
9 | FEITAI | Author keyword | 3 | 100% | 0% | 3 |
10 | BLEOMYCINE | Author keyword | 2 | 67% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | BLEOMYCIN | 37 | 15% | 17% | 226 | Search BLEOMYCIN | Search BLEOMYCIN |
2 | PULMONARY FIBROSIS | 26 | 13% | 15% | 195 | Search PULMONARY+FIBROSIS | Search PULMONARY+FIBROSIS |
3 | LUNG FIBROSIS | 10 | 15% | 5% | 65 | Search LUNG+FIBROSIS | Search LUNG+FIBROSIS |
4 | BLEOMYCIN INDUCED LUNG INJURY | 3 | 57% | 0% | 4 | Search BLEOMYCIN+INDUCED+LUNG+INJURY | Search BLEOMYCIN+INDUCED+LUNG+INJURY |
5 | FEITAI | 3 | 100% | 0% | 3 | Search FEITAI | Search FEITAI |
6 | BLEOMYCINE | 2 | 67% | 0% | 2 | Search BLEOMYCINE | Search BLEOMYCINE |
7 | BRONCHOALVEOLAR STEM CELL | 2 | 67% | 0% | 2 | Search BRONCHOALVEOLAR+STEM+CELL | Search BRONCHOALVEOLAR+STEM+CELL |
8 | ULTRASHORT ECHO TIME UTE | 2 | 67% | 0% | 2 | Search ULTRASHORT+ECHO+TIME+UTE | Search ULTRASHORT+ECHO+TIME+UTE |
9 | PERIBRONCHIAL LYMPHATIC TISSUE | 1 | 100% | 0% | 2 | Search PERIBRONCHIAL+LYMPHATIC+TISSUE | Search PERIBRONCHIAL+LYMPHATIC+TISSUE |
10 | PEPLOMYCIN | 1 | 20% | 0% | 6 | Search PEPLOMYCIN | Search PEPLOMYCIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INDUCED PULMONARY FIBROSIS | 47 | 20% | 16% | 207 |
2 | INDUCED LUNG FIBROSIS | 24 | 27% | 6% | 77 |
3 | INHIBITS FIBROBLAST | 13 | 58% | 1% | 15 |
4 | FIBROTIC LUNG FIBROBLASTS | 10 | 57% | 1% | 12 |
5 | E PROSTANOID 2 RECEPTOR | 10 | 58% | 1% | 11 |
6 | ENDOTRACHEAL BLEOMYCIN | 9 | 64% | 1% | 9 |
7 | ALVEOLAR DUCT REGIONS | 6 | 80% | 0% | 4 |
8 | INTRATRACHEAL BLEOMYCIN | 4 | 38% | 1% | 9 |
9 | ERDOSTEINE | 4 | 31% | 1% | 11 |
10 | HAMSTER LUNGS | 3 | 32% | 1% | 7 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis? | 2008 | 209 | 208 | 50% |
Murine models of pulmonary fibrosis | 2008 | 220 | 76 | 39% |
Pulmonary fibrosis - Searching for model answers | 2005 | 124 | 25 | 48% |
The role of transforming growth factor beta in lung development and disease | 2004 | 214 | 132 | 29% |
The role of miR-29 in pulmonary fibrosis | 2015 | 1 | 117 | 11% |
Pulmonary fibrosis: pathogenesis, etiology and regulation | 2009 | 164 | 334 | 13% |
Fibrosis of the lung and other tissues: New concepts in pathogenesis and treatment | 2001 | 190 | 96 | 22% |
Therapies for bleomycin induced lung fibrosis through regulation of TGF-beta 1 induced collagen gene expression | 2007 | 62 | 39 | 21% |
FIBROGENIC CYTOKINES AND CONNECTIVE-TISSUE PRODUCTION | 1994 | 307 | 64 | 19% |
C-C chemokines: Novel mediators of the profibrotic inflammatory response to bleomycin challenge | 1996 | 67 | 98 | 41% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LUNG CELLULAR MOL BIOL | 6 | 40% | 0.9% | 12 |
2 | MED SL9 | 4 | 75% | 0.2% | 3 |
3 | MALLORY PATHOL | 4 | 28% | 0.9% | 12 |
4 | LUNG BIOL PROGRAM | 3 | 20% | 1.1% | 15 |
5 | PULM SECT 111G | 1 | 50% | 0.2% | 2 |
6 | SECT PULM DIS CRIT CARE ENVIRONM MED | 1 | 16% | 0.5% | 7 |
7 | DTA INFLAMMAT | 1 | 40% | 0.2% | 2 |
8 | PNEUMOCONIOSIS | 1 | 13% | 0.5% | 6 |
9 | CARDIOPULM BIOCHEM P MED | 1 | 13% | 0.4% | 5 |
10 | ARMY P ALLERG DIS DIAG MANAGEMENT | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000246835 | SHOCK TRAUMA S//SURG ALPERT MED//A549 CELL APOPTOSIS |
2 | 0.0000166440 | IDIOPATHIC PULMONARY FIBROSIS//USUAL INTERSTITIAL PNEUMONIA//IDIOPATHIC INTERSTITIAL PNEUMONIA |
3 | 0.0000159820 | PULMONARY TOXICITY//PULM DIS INTENS CARE//GEFITINIB IRESSA |
4 | 0.0000123394 | PIRFENIDONE//FLUOROFENIDONE//AKF PD |
5 | 0.0000119057 | SILICOSIS//PRIMARY HLTH CARE PREVENT MED//COAL WORKERS PNEUMOCONIOSIS |
6 | 0.0000095200 | SPECIALTY CARE SERV//PULM CRIT CARE MEDMED//ANTIPLASMINS |
7 | 0.0000089851 | FIBROCYTES//FIBROCYTE//RENAL FIBROSIS |
8 | 0.0000086761 | PHOSPHATIDYLCHOLINE SECRETION//PNEUMOCYTE TYPE II//METAL AEROSOL |
9 | 0.0000083919 | LARP6//ALPHA 2I COLLAGEN//DERIVATIVE OF ERYTHROMYCIN |
10 | 0.0000073765 | BLEOMYCIN HYDROLASE//BLEOMYCIN BINDING PROTEIN//BLEOMYCIN RESISTANCE |